Citation Impact
Citing Papers
Combination Therapy of Bortezomib with Novel Targeted Agents: An Emerging Treatment Strategy
2010
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
2007 Standout
Epidemiology and causes of preterm birth
2008 Standout
Multiple myeloma
2014
Advances in stem cell mobilization
2014
Disease relapse after haematopoietic stem cell transplantation: Risk factors and treatment
2007
Characteristics of bortezomib‐ and thalidomide‐induced peripheral neuropathy
2008
Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft‐versus‐host disease after allogeneic transplantation
2005
Cardiac Involvement with Lymphoma: A Review of the Literature
2008
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
The role of liposomes in clinical nanomedicine development. What now? Now what?
2019 Standout
Neutrophils at work
2014 Standout
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
2002 Standout
Advances in stem cell mobilization
2012
Risk assessment in haemotopoietic stem cell transplantation: Disease and disease stage
2007
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
2001 Standout
Hematopoietic growth factors: ESMO Recommendations for the applications
2009
Comparison of 200 mg/m2 melphalan and 8 Gy total body irradiation plus 140 mg/m2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myelome 9502 randomized trial
2002 Standout
Prevention of VTE in Nonsurgical Patients
2012 Standout
Vascular disorders of the liver # †
2008 Standout
Bortezomib represses HIF-1α protein expression and nuclear accumulation by inhibiting both PI3K/Akt/TOR and MAPK pathways in prostate cancer cells
2011
Chronic graft-versus-host disease
2003 Standout
Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
2014 Standout
Cancer genes and the pathways they control
2004 Standout
New drugs in multiple myeloma: mechanisms of action and phase I/II clinical findings
2008
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Graft-versus-host disease
2009 Standout
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Elderly age and prior autologous transplantation have a deleterious effect on survival following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results from the Spanish multicenter prospective trial
2004
The Threshold for Prophylactic Platelet Transfusions in Adults with Acute Myeloid Leukemia
1997
Immunity, Inflammation, and Cancer
2010 Standout
Biology and management of relapsed acute myeloid leukaemia
2005
Chronic Myelogenous Leukemia
2002
Prevention of Venous Thromboembolism
2004 Standout
Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study
2002
Pregnancy outcome in hematologic malignancies
1991
Hematopoietic Stem-Cell Transplantation
2006 Standout
Extracorporeal light chain elimination: high cut-off (HCO) hemodialysis parallel to chemotherapy allows for a high proportion of renal recovery in multiple myeloma patients with dialysis-dependent acute kidney injury
2011
Treatment of Relapsed/Refractory Multiple Myeloma
2009
The use of novel agents in the treatment of relapsed and refractory multiple myeloma
2009
Pathogenesis and treatment of renal failure in multiple myeloma
2008
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Fadiga relacionada ao câncer: uma revisão
2011 Standout
A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10,000/L versus 20,000/microL trigger
2002
Idarucizumab for Dabigatran Reversal
2015 Standout
Prevention of Venous Thromboembolism
2008 Standout
Drug Insight: thalidomide as a treatment for multiple myeloma
2005
Pegylated liposomal doxorubicin, vincristine, and dexamethasone provide significant reduction in toxicity compared with doxorubicin, vincristine, and dexamethasone in patients with newly diagnosed multiple myeloma
2006
Infections in Patients with Multiple Myeloma in the Era of High‐Dose Therapy and Novel Agents
2009
Guidelines for the use of platelet transfusions
2016
Long‐term hematologic reconstitution after autologous peripheral blood progenitor cell transplantation: a comparison between controlled‐rate freezing and uncontrolled‐rate freezing at 80°C
2003
Defining the Intensity of Conditioning Regimens: Working Definitions
2009 Standout
Disseminated Intravascular Coagulation
1999 Standout
Assessing the Adequacy of Vascular Access and Its Relationship to Patient Outcome
1994
Proteasome Inhibitors with Photocontrolled Activity
2014 StandoutNobel
Blockade of interleukin‐6 signalling with siltuximab enhances melphalan cytotoxicity in preclinical models of multiple myeloma
2011
Hematopoietic growth factors: ESMO Clinical Practice Guidelines for the applications
2010
The effect of maternal work on fetal growth and duration of pregnancy: a prospective study
1990
Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies
2012
Treatment of Multiple Myeloma: A Comprehensive Review
2009
Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT
2005
Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapy
2009
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
2012 StandoutNobel
Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma
2007
Overview of Platelet Transfusion
2010
ACVIM consensus statement: Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats
2018 Standout
The Use of Darbepoetin to Stimulate Erythropoiesis in the Treatment of Anemia of Chronic Kidney Disease in Dogs
2017
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Interferon-γ: an overview of signals, mechanisms and functions
2003 Standout
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS)
2018 Standout
Meta-analysis: Effect of Prophylactic Hematopoietic Colony-Stimulating Factors on Mortality and Outcomes of Infection
2007
Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
2009 Standout
Allogeneic Transplant with Reduced Intensity Conditioning Regimens may Overcome the Poor Prognosis of B-Cell Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Variable Heavy-Chain Gene and Chromosomal Abnormalities (11q− and 17p−)
2005
Acute leukemia during pregnancy: the Toronto Leukemia Study Group experience with long-term follow-up of children exposed in utero to chemotherapeutic agents.
1987
Bortezomib Plus Melphalan and Prednisone Compared With Melphalan and Prednisone in Previously Untreated Multiple Myeloma: Updated Follow-Up and Impact of Subsequent Therapy in the Phase III VISTA Trial
2010
Thalidomide and thrombosis
2007
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Neue Ziele für die Photopharmakologie
2016 StandoutNobel
Platelet Transfusion for Patients With Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology*
2001
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Bortezomib Plus Dexamethasone Is Superior to Vincristine Plus Doxorubicin Plus Dexamethasone As Induction Treatment Prior to Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: Results of the IFM 2005-01 Phase III Trial
2010
Individualizing Treatment of Patients With Myeloma in the Era of Novel Agents
2008
Improved survival in multiple myeloma and the impact of novel therapies
2007 Standout
Conditioning regimens for hematopoietic cell transplantation: one size does not fit all
2014
Autologous Stem Cell Transplantation in Acute Myelocytic Leukemia
1998
Proteasome Inhibition Alleviates SNARE-Dependent Neurodegeneration
2012 StandoutNobel
An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology.
1999
Autologous Stem Cell Transplantation in Acute Myelocytic Leukemia
1998
Allogeneic Peripheral Blood Stem Cell Transplantation May Be Associated With a High Risk of Chronic Graft-Versus-Host Disease
1997
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
2005 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
How I treat multiple myeloma in younger patients
2009
Emerging Targets in Photopharmacology
2016 StandoutNobel
Rapid Engraftment Without Significant Graft-Versus-Host Disease After Allogeneic Transplantation of CD34+ Selected Cells From Peripheral Blood
1997
Recommendations for the transfusion of plasma and platelets.
2009
KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update
2020 Standout
Evaluation of Hematological Reconstitution Potential of Autologous Peripheral Blood Progenitor Cells Cryopreserved by a Simple Controlled-Rate Freezing Method
2004 StandoutNobel
Multiple Myeloma
2011 Standout
Erythropoietin or darbepoetin for patients with cancer
2012
Meta-Analysis of Randomized Controlled Trials of Prophylactic Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor After Autologous and Allogeneic Stem Cell Transplantation
2006
Interferon in Oncological Practice: Review of Interferon Biology, Clinical Applications, and Toxicities
2001
Chronic Myelogenous Leukemia: Biology and Therapy
1999
Works of Adrían Alegre being referenced
Influence of Pre- and Post-Transplantation Responses on Outcome of Patients With Multiple Myeloma: Sequential Improvement of Response and Achievement of Complete Response Are Associated With Longer Survival
2008
Clinical results of a stringent policy on prophylactic platelet transfusion: non-randomized comparative analysis in 190 bone marrow transplant patients from a single institution.
1996
Bortezomib is an efficient agent in plasma cell leukemias
2004
Effect of Hemodialysis on Protein C Levels
1987
Busulfan and melphalan as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma
1995
Methylene blue‐photoinactivated plasma versus quarantine fresh frozen plasma in thrombotic thrombocytopenic purpura: a multicentric, prospective cohort study
2008
The efficacy and safety of lenalidomide plus dexamethasone in relapsed and/or refractory multiple myeloma patients with impaired renal function
2010
Chronic but not acute graft‐versus‐host disease improves outcome in multiple myeloma patients after non‐myeloablative allogeneic transplantation
2003
Absence of influence of prior treatment with interferon on the outcome of allogeneic bone marrow transplantation for chronic myeloid leukemia
1998
Lenograstim after autologous peripheral blood progenitor cell transplantation: results of a double-blind, randomized trial
2004
Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma
2004
Veno-Occlusive Disease of the Liver after High-Dose Cytoreductive Therapy with Busulfan and Melphalan for Autologous Blood Stem Cell Transplantation in Multiple Myeloma Patients
2007
The oral combination of thalidomide, cyclophosphamide and dexamethasone (ThaCyDex) is effective in relapsed/refractory multiple myeloma
2004
Phase II Pethema Trial of Alternating Bortezomib and Dexamethasone As Induction Regimen Before Autologous Stem-Cell Transplantation in Younger Patients With Multiple Myeloma: Efficacy and Clinical Implications of Tumor Response Kinetics
2007
Controlled-rate versus uncontrolled-rate cryopreservation of peripheral blood progenitor cells: a prospective multicenter study. Group for Cryobiology and Biology of Bone Marrow Transplantation (CBTMO), Spain.
1998
Different patterns of relapse after autologous peripheral blood stem cell transplantation in multiple myeloma: clinical results of 280 cases from the Spanish Registry
2002
[Bone marrow autotransplantation in acute myeloblastic leukemia in its first complete remission. The clinical results in 41 patients].
1997
Stem Cell Factor in Combination With Filgrastim After Chemotherapy Improves Peripheral Blood Progenitor Cell Yield and Reduces Apheresis Requirements in Multiple Myeloma Patients: A Randomized, Controlled Trial
1999
Successful pregnancy in acute promyelocytic leukemia
1982
Autologous or allogeneic bone marrow transplantation for acute myeloblastic leukemia in second complete remission. Importance of duration of first complete remission in final outcome.
1996
Incidence and characterization of secondary myelodysplastic syndromes following autologous transplantation.
2000
A prospective observational study of the effectiveness, safety, and effect on fatigue of darbepoetin alfa for the treatment of chemotherapy-induced anaemia
2008
Preliminary Results of CNTO 328, An Anti-Interleukin-6 Monoclonal Antibody, in Combination with Bortezomib in the Treatment of Relapsed or Refractory Multiple Myeloma
2008
Allogeneic peripheral blood progenitor cell transplantation: analysis of short-term engraftment and acute GVHD incidence in 33 cases. allo-PBPCT Spanish Group.
1996
Influence of work during pregnancy on fetal weight.
1984